$125 | Single User
$250 | Site License
$375 | Global License

Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review [Report Updated: 14-03-2018]

Published by Global Data: 14 Mar 2018 | 203374 | In Stock

Introduction

Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Concert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology company which discovers and develops small molecule drugs. The company develops its products using its deuterated chemical entity (DCE) platform to develop novel therapeutics for autoimmune and inflammatory diseases, pulmonary diseases, and disorders of central nervous system (CNS). Its product pipeline includes CTP-543 (deuterated ruxolitinib) for alopecia areata; AVP-786 (deuterated dextromethorphan) indicated for alzheimer’s agitation, major depressive disorder and residual schizophrenia; CTP-730 (deuterated apremilast) for inflammatory diseases; CTP-692, a selective DCE modified analog of the endogenous amino acid, D-serine for Schizophrenia, and JZP-386 (deuterated sodium-oxybate) for narcolepsy. It employs its deuterated compounds to reduce the extent of metabolism in the wall of the intestines and in the liver. Concert Pharmaceuticals is headquartered in Lexington, Massachusetts, the US.

Concert Pharmaceuticals Inc Key Recent Developments

Mar 01,2018: Concert Pharmaceuticals Reports Year Ended 2017 Financial Results

Jan 12,2018: Concert Pharmaceuticals Announces Patent Trial and Appeal Board Did Not Institute PGR Proceeding

Dec 18,2017: Concert Pharmaceuticals Announces the Appointment of Marc Becker as Chief Financial Officer

Dec 13,2017: Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index

Nov 09,2017: Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review [Report Updated: 14-03-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    Section 1 - About the Company 6

    Concert Pharmaceuticals Inc - Key Facts 6

    Concert Pharmaceuticals Inc - Key Employees 7

    Concert Pharmaceuticals Inc - Key Employee Biographies 8

    Concert Pharmaceuticals Inc - Major Products and Services 9

    Concert Pharmaceuticals Inc - History 10

    Concert Pharmaceuticals Inc - Company Statement 12

    Concert Pharmaceuticals Inc - Locations And Subsidiaries 15

    Head Office 15

    Other Locations & Subsidiaries 15

    Section 2 – Company Analysis 16

    Company Overview 16

    Concert Pharmaceuticals Inc - Business Description 16

    R&D Overview 16

    Concert Pharmaceuticals Inc - Corporate Strategy 18

    Concert Pharmaceuticals Inc - SWOT Analysis 19

    SWOT Analysis - Overview 19

    Concert Pharmaceuticals Inc - Strengths 19

    Concert Pharmaceuticals Inc - Weaknesses 20

    Concert Pharmaceuticals Inc - Opportunities 21

    Concert Pharmaceuticals Inc - Threats 22

    Concert Pharmaceuticals Inc - Key Competitors 23

    Section 3 – Company Financial Ratios 24

    Financial Ratios - Capital Market Ratios 24

    Financial Ratios - Annual Ratios 25

    Performance Chart 28

    Financial Performance 28

    Financial Ratios - Interim Ratios 29

    Financial Ratios - Ratio Charts 30

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 31

    Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

    Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

    Concert Pharmaceuticals Inc, Recent Deals Summary 33

    Section 5 – Company’s Recent Developments 34

    Mar 01, 2018: Concert Pharmaceuticals Reports Year Ended 2017 Financial Results 34

    Jan 12, 2018: Concert Pharmaceuticals Announces Patent Trial and Appeal Board Did Not Institute PGR Proceeding 35

    Dec 18, 2017: Concert Pharmaceuticals Announces the Appointment of Marc Becker as Chief Financial Officer 36

    Dec 13, 2017: Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index 37

    Nov 09, 2017: Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update 38

    Aug 08, 2017: Concert Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Company Update 39

    May 30, 2017: Concert Pharmaceuticals Announces Departure of Chief Financial Officer, Ryan Daws 41

    May 02, 2017: Concert Pharmaceuticals Reports First Quarter 2017 Financial Results 42

    Mar 06, 2017: Concert Pharmaceuticals Reports Year Ended 2016 Financial Results 43

    Section 6 – Appendix 45

    Methodology 45

    Ratio Definitions 45

    About GlobalData 49

    Contact Us 49

    Disclaimer 49

List Of Tables
in Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review [Report Updated: 14-03-2018]

List of Tables

Concert Pharmaceuticals Inc, Key Facts 6

Concert Pharmaceuticals Inc, Key Employees 7

Concert Pharmaceuticals Inc, Key Employee Biographies 8

Concert Pharmaceuticals Inc, Major Products and Services 9

Concert Pharmaceuticals Inc, History 10

Concert Pharmaceuticals Inc, Subsidiaries 15

Concert Pharmaceuticals Inc, Key Competitors 23

Concert Pharmaceuticals Inc, Ratios based on current share price 24

Concert Pharmaceuticals Inc, Annual Ratios 25

Concert Pharmaceuticals Inc, Annual Ratios (Cont...1) 26

Concert Pharmaceuticals Inc, Annual Ratios (Cont...2) 27

Concert Pharmaceuticals Inc, Interim Ratios 29

Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Concert Pharmaceuticals Inc, Recent Deals Summary 33

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

List Of Figures, Charts and Diagrams
in Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review [Report Updated: 14-03-2018]

List of Figures

Concert Pharmaceuticals Inc, Performance Chart (2013 - 2017) 28

Concert Pharmaceuticals Inc, Ratio Charts 30

Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

Additional Details

Publisher

Global Data

Publisher Information

Reference

203374 | GDPH137836FSA

Number of Pages

49

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review
SummaryConcert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology compa...
07 Aug 2017 by Global Data USD $300 More Info
Concert Pharmaceuticals Inc (CNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryConcert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology compa...
26 Jul 2017 by Global Data USD $250 More Info
Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review
SummaryConcert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology compa...
15 May 2017 by Global Data USD $300 More Info
Concert Pharmaceuticals Inc (CNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryConcert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology compa...
23 Feb 2017 by Global Data USD $250 More Info
Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review
SummaryConcert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology compa...
13 Jan 2017 by Global Data USD $300 More Info
Concert Pharmaceuticals Inc (CNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryConcert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology compa...
24 Nov 2016 by Global Data USD $250 More Info
Concert Pharmaceuticals, Inc. (CNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryConcert Pharmaceuticals, Inc. (Concert Pharmaceuticals) is a clinical stage biotechnology com...
24 Aug 2016 by Global Data USD $250 More Info
Concert Pharmaceuticals, Inc. (CNCE) - Financial and Strategic SWOT Analysis Review
SummaryConcert Pharmaceuticals, Inc. (Concert Pharmaceuticals) is a clinical stage biotechnology com...
11 Jul 2016 by Global Data USD $300 More Info
Concert Pharmaceuticals, Inc. (CNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryConcert Pharmaceuticals, Inc. (Concert Pharmaceuticals) is a pharmaceutical company that crea...
06 May 2016 by Global Data USD $250 More Info
Concert Pharmaceuticals, Inc. (CNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryConcert Pharmaceuticals, Inc. (Concert Pharmaceuticals) is a pharmaceutical company that crea...
09 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Concert Pharmaceuticals Inc (CNCE) - Financial and Strategic SWOT Analysis Review [Report Updated: 14-03-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data